医学
结直肠癌
淋巴血管侵犯
内科学
单变量分析
化疗
肿瘤科
胃肠病学
多元分析
淋巴结
癌症
根治性手术
转移
外科
作者
Soichiro Minami,Norikatsu Miyoshi,Shiki Fujino,Shinya Kato,Yuki Sekido,Tsuyoshi Hata,Takayuki Ogino,Hidekazu Takahashi,Mamoru Uemura,Hirofumi Yamamoto,Yuichiro� Doki,Hidetoshi Eguchi
出处
期刊:Anticancer Research
[Anticancer Research USA Inc.]
日期:2022-07-01
卷期号:42 (7): 3759-3766
被引量:4
标识
DOI:10.21873/anticanres.15866
摘要
There are few reports on the clinical significance of the geriatric nutritional risk index (GNRI) in patients with locally advanced rectal cancer who undergo preoperative chemotherapy (NAC, neoadjuvant chemotherapy) followed by radical resection; this study examined the relationship between preoperative GNRI, postoperative complications, and prognosis in these patients.Fifty-seven patients with rectal cancer who underwent radical resection after NAC at Osaka University Hospital between November 2011 and May 2018 were included. The GNRI was calculated as follows: GNRI= [1.489×serum albumin level (g/l)]+[41.7×present/ideal body weight (kg)]. Patients were classified into high (GNRI ≥96.74; n=36) and low GNRI (GNRI <96.74; n=21) groups, based on the results of the receiver operating characteristic curve analysis.The Kaplan-Meier analysis showed that the low GNRI group had a significantly poorer cancer-specific survival (CSS) and a poorer overall survival tendency than the high GNRI group. In the univariate analysis, venous invasion, lymphatic vessel invasion, and low GNRI were significantly correlated with CSS; depth of tumor invasion, lymph node metastasis, and lymphatic vessel invasion were significantly correlated with disease-free survival (DFS). In the multivariate analysis, there were no significantly poor prognostic factors for CSS and DFS.Preoperative GNRI may be a useful predictor for recurrence and poor prognosis in elderly patients with rectal cancer who undergo radical resection after NAC. Further studies and accumulation of cases should investigate the relationship between preoperative GNRI and prognosis after NAC in elderly patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI